A field of Evusheld, an antibody remedy developed by pharmaceutical firm AstraZeneca for the prevention of COVID-19 in immunocompromised sufferers, is seen in February on the AstraZeneca facility for organic medicines in Sweden
Jonathan Nackstrand/AFP through Getty Photographs
cover caption
toggle caption
Jonathan Nackstrand/AFP through Getty Photographs
A field of Evusheld, an antibody remedy developed by pharmaceutical firm AstraZeneca for the prevention of COVID-19 in immunocompromised sufferers, is seen in February on the AstraZeneca facility for organic medicines in Sweden
Jonathan Nackstrand/AFP through Getty Photographs
The federal authorities is making an attempt to make it simpler for immunocompromised sufferers entry a remedy that may defend them towards COVID-19 by permitting particular person well being care suppliers to order small quantities — as much as three affected person programs at a time, in response to a Well being and Human Companies Division spokesperson.
“This new pathway shall be notably helpful for well being care suppliers in rural areas and others that would not have a big pool of sufferers requiring the remedy,” the spokesperson stated.
As well as, Evusheld shall be accessible by means of a subset of federal pharmacy companions, together with Albertsons, Acme, Jewel-Osco, Pavilions, Randalls, Safeway, Star Market, and Vons, CPESN, Hy-Vee, Amber Specialty Pharmacy, Managed Healthcare Associates and Thrifty White.
The federal government can also be working with AstraZeneca, which makes Evusheld, to arrange a toll-free quantity (1-833-EVUSHLD — 1-833-388-7453) to make it simpler for well being care suppliers to get details about the remedy, together with order it.
Evusheld consists of two antibodies which can be injected, and can assist defend sufferers for as much as six months.
The Biden administration has secured 1.7 million doses of Evusheld.
